Plato Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98M | Buy |
3,779
+2
| +0.1% | +$1.05K | 0.15% | 154 |
|
|
2025
Q1 | $2.42M | Buy |
3,777
+1,116
| +42% | +$715K | 0.2% | 121 |
|
|
2024
Q4 | $1.9M | Buy |
2,661
+44
| +2% | +$31.5K | 0.14% | 159 |
|
|
2024
Q3 | $2.75M | Buy |
2,617
+79
| +3% | +$83K | 0.22% | 113 |
|
|
2024
Q2 | $2.67M | Buy |
2,538
+144
| +6% | +$151K | 0.25% | 94 |
|
|
2024
Q1 | $2.3M | Buy |
2,394
+2,271
| +1,846% | +$2.19M | 0.24% | 109 |
|
|
2023
Q4 | $108K | Buy |
+123
| New | +$108K | 0.13% | 150 |
|